Literature DB >> 25131402

Bacteria-phage interactions in natural environments.

Samuel L Díaz-Muñoz1, Britt Koskella2.   

Abstract

Phages are considered the most abundant and diverse biological entities on Earth and are notable not only for their sheer abundance, but also for their influence on bacterial hosts. In nature, bacteria-phage relationships are complex and have far-reaching consequences beyond particular pairwise interactions, influencing everything from bacterial virulence to eukaryotic fitness to the carbon cycle. In this review, we examine bacteria and phage distributions in nature first by highlighting biogeographic patterns and nonhost environmental influences on phage distribution, then by considering the ways in which phages and bacteria interact, emphasizing phage life cycles, bacterial responses to phage infection, and the complex patterns of phage host specificity. Finally, we discuss phage impacts on bacterial abundance, genetics, and physiology, and further aim to clarify distinctions between current theoretical models and point out areas in need of future research.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteriophage; Coevolution; Frequency-dependent selection; Kill the Winner; Microbial diversity; Phage therapy

Mesh:

Year:  2014        PMID: 25131402     DOI: 10.1016/B978-0-12-800259-9.00004-4

Source DB:  PubMed          Journal:  Adv Appl Microbiol        ISSN: 0065-2164            Impact factor:   5.086


  57 in total

1.  Multiple mechanisms drive phage infection efficiency in nearly identical hosts.

Authors:  Cristina Howard-Varona; Katherine R Hargreaves; Natalie E Solonenko; Lye Meng Markillie; Richard Allen White; Heather M Brewer; Charles Ansong; Galya Orr; Joshua N Adkins; Matthew B Sullivan
Journal:  ISME J       Date:  2018-03-22       Impact factor: 10.302

Review 2.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

3.  Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant Stenotrophomonas maltophilia in a Mouse Model.

Authors:  Pengjun Han; Wenjing Zhang; Mingfang Pu; Yahao Li; Lihua Song; Xiaoping An; Mengzhe Li; Fei Li; Shuyan Zhang; Huahao Fan; Yigang Tong
Journal:  Front Microbiol       Date:  2022-07-05       Impact factor: 6.064

4.  High-throughput mapping of the phage resistance landscape in E. coli.

Authors:  Vivek K Mutalik; Benjamin A Adler; Harneet S Rishi; Denish Piya; Crystal Zhong; Britt Koskella; Elizabeth M Kutter; Richard Calendar; Pavel S Novichkov; Morgan N Price; Adam M Deutschbauer; Adam P Arkin
Journal:  PLoS Biol       Date:  2020-10-13       Impact factor: 8.029

5.  Reply to Jobling, "Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not Proven".

Authors:  Leanid Laganenka; Victor Sourjik
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

6.  Investigation of a Large Collection of Pseudomonas aeruginosa Bacteriophages Collected from a Single Environmental Source in Abidjan, Côte d'Ivoire.

Authors:  Christiane Essoh; Libera Latino; Cédric Midoux; Yann Blouin; Guillaume Loukou; Simon-Pierre A Nguetta; Serge Lathro; Arsher Cablanmian; Athanase K Kouassi; Gilles Vergnaud; Christine Pourcel
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

7.  Quality and safety requirements for sustainable phage therapy products.

Authors:  Jean-Paul Pirnay; Bob G Blasdel; Laurent Bretaudeau; Angus Buckling; Nina Chanishvili; Jason R Clark; Sofia Corte-Real; Laurent Debarbieux; Alain Dublanchet; Daniel De Vos; Jérôme Gabard; Miguel Garcia; Marina Goderdzishvili; Andrzej Górski; John Hardcastle; Isabelle Huys; Elizabeth Kutter; Rob Lavigne; Maia Merabishvili; Ewa Olchawa; Kaarle J Parikka; Olivier Patey; Flavie Pouilot; Gregory Resch; Christine Rohde; Jacques Scheres; Mikael Skurnik; Mario Vaneechoutte; Luc Van Parys; Gilbert Verbeken; Martin Zizi; Guy Van den Eede
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

Review 8.  Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Authors:  Stephen T Abedon
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-09

9.  The Molecular and Genetic Basis of Repeatable Coevolution between Escherichia coli and Bacteriophage T3 in a Laboratory Microcosm.

Authors:  Elizabeth B Perry; Jeffrey E Barrick; Brendan J M Bohannan
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

10.  The evolution of bacterial resistance against bacteriophages in the horse chestnut phyllosphere is general across both space and time.

Authors:  Britt Koskella; Nicole Parr
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.